Physician profile
Francesca Johnson
NPI 1255427571
$1,757.20
in general payments reported to CMS, 2019-2025
17 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $175 · 2021: $233 · 2022: $169 · 2023: $261 · 2024: $389 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $266.03 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $247.30 | 2019-2025 | Precision7 |
| Glaukos Corporation | $225.40 | 2024 | Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Allergan, INC. | $206.64 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $189.11 | 2022-2024 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $139.39 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $104.77 | 2023 | Syfovre |
| Johnson & Johnson Vision Care, INC. | $96.89 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $63.06 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $45.69 | 2019 | |
| Abb Con-Cise Optical Group LLC | $37.44 | 2019-2021 | |
| Shire North American Group INC | $37.22 | 2019 | |
| Aerie Pharmaceuticals, INC. | $35.56 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Lombart Brothers, INC. | $16.50 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.12 | 2020 | |
| Eyevance Pharmaceuticals LLC | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francesca Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.